Fidelity International’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.3M Buy
856,214
+27,267
+3% +$3.3M 0.07% 252
2026
Q1
$136M Sell
828,947
-9,562
-1% -$1.47M 0.11% 203
2025
Q4
$146M Sell
838,509
-13,445
-2% -$2.45M 0.11% 199
2025
Q3
$123M Sell
851,954
-313,510
-27% -$38.4M 0.1% 204
2025
Q2
$117M Sell
1,165,464
-1,224,737
-51% -$93.6M 0.1% 208
2025
Q1
$182M Sell
2,390,201
-247,959
-9% -$19M 0.17% 149
2024
Q4
$182M Buy
2,638,160
+198,412
+8% +$14.3M 0.17% 149
2024
Q3
$178M Buy
2,439,748
+921,634
+61% +$68M 0.16% 161
2024
Q2
$102M Buy
1,518,114
+797,869
+111% +$30.9M 0.1% 213
2024
Q1
$19.5M Buy
720,245
+28,814
+4% +$806K 0.02% 447
2023
Q4
$21.4M Sell
691,431
-139,771
-17% -$3.62M 0.02% 412
2023
Q3
$21M Buy
831,202
+474,805
+133% +$10.9M 0.02% 402
2023
Q2
$7.52M Sell
356,397
-83,126
-19% -$1.58M 0.01% 520
2023
Q1
$7.49M Buy
439,523
+143,313
+48% +$2.78M 0.01% 520
2022
Q4
$5.92M Buy
296,210
+283,487
+2,228% +$5.48M 0.01% 557
2022
Q3
$274K Buy
+12,723
New +$305K ﹤0.01% 760

Other funds holding INSM

Fidelity International's INSM Position: Q2 2026 in Review

Fidelity International increased its Insmed (INSM) stake by 3.3% in Q2 2026, buying an estimated $3.3M and bringing the position to 856,214 shares worth $91.3M. The position accounts for 0.07% of the portfolio, ranked #252.

Fidelity International first reported a position in INSM in Q3 2022 and has held it in 16 quarters since. The position peaked at $182M in Q1 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Fidelity International held 856,214 shares of Insmed worth $91.3M as of Q2 2026.
  • Fidelity International bought 27,267 Insmed shares in Q2 2026, an estimated $3.3M.
  • Insmed made up 0.07% of Fidelity International's portfolio in Q2 2026, its #252 holding.
  • Fidelity International first reported a position in Insmed in Q3 2022 and has held it in 16 quarters since.
  • Fidelity International's Insmed position peaked at $182M in Q1 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.